---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-016000"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-18T23:19:27.278225+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Elite Pharmaceuticals to report FY2025 results June 30, host call July 1

## Summary
- FY2025 (ended March 31, 2025) financial results to be released June 30, 2025.
- Conference call to discuss results on July 1, 2025 at 11:30 AM EDT.
- Dial-in: 1-800-346-7359 (domestic) or 1-973-528-0008 (international); ID 98840.
- Shareholders can email questions to dianne@elitepharma.com by respective deadlines.

## SEC filing metadata
- accession: 0001641172-25-016000
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000164117225016000/0001641172-25-016000-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000164117225016000/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-016000
- JSON: https://secwatch.observer/filing/0001641172-25-016000.json
- Plain text: https://secwatch.observer/filing/0001641172-25-016000.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.